Alkermes

United States
Wilmington, Ohio, Ireland, 45177

Company profile

Alkermes company profile

Alkermes Wilmington supports the operations of Alkermes plc, a global biopharmaceutical company focused on central nervous system disorders and oncology.

Business identity

Contact email
[email protected]
Phone number
+353 1 772 8000
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Revenue range
$100M-$1B
Founded
1987-01-01, Year

Headquarters

Postal code
45177
Country code
US
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
2
Total equity funding
$250M
Last funding
Post IPO Equity / 2017-11-20
Last equity funding
Post IPO Equity
Investors
2
Lead investors
1
Founders
3
Articles
708
Exited on
2011-09-16

Founders and investors

Founders

Floyd BloomJohn ClarkePaul Schimmel

Lead investors

Primecap Management

Investors

InvescoPrimecap Management